Gts Securities LLC Novartis Ag Call Options Transaction History

Gts Securities LLC

  • $46.5 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$92.57 - $107.37 $212,910 - $246,951
-2,300 Reduced 6.41%
33,600 $3.58 Million
Q1 2024

May 15, 2024
SELL
$95.27 - $108.47 $4.27 Million - $4.86 Million
-44,800 Reduced 55.51%
35,900 $3.47 Million
Q4 2023

Feb 14, 2024
SELL
$92.27 - $101.54 $1.27 Million - $1.4 Million
-13,800 Reduced 14.6%
80,700 $8.15 Million
Q3 2023

Nov 15, 2023
BUY
$94.73 - $105.13 $8.95 Million - $9.93 Million
94,500 New
94,500 $9.63 Million

Others Institutions Holding NVS

# of Institutions
1,426
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email